newsThe US government will develop and manufacture AstraZeneca’s investigational monoclonal…
13 October 2020 | By Hannah Balfour (European Pharmaceutical Review)
The US government will develop and manufacture AstraZeneca’s investigational monoclonal antibody cocktail, AZD7442, a potential prophylactic treatment for COVID-19.